NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

Historical Holders from Q1 2014 to Q3 2025

Symbol: NBIX on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 99.6M
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 96.8M
Holdings value: $13.6B
% of all portfolios: 0.012%
Grand Portfolio weight change: 0%
Number of holders: 633
Number of buys: 329
Number of sells: -269
Average Value change %: 0%
Average buys %: +0.003%
Average sells %: -0.005%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
BlackRock, Inc.	12.1%	$1.27B	12.1M	BlackRock, Inc.	31 Mar 2025
VANGUARD GROUP INC	10.15%	$1.07B	10.1M	The Vanguard Group	28 Feb 2025
DODGE & COX	5.6%	$585M	5.53M	Dodge & Cox	31 Mar 2025
STATE STREET CORP	4.8%	$517M	4.89M	STATE STREET CORPORATION	31 Dec 2024

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	96.8M	$13.6B	-$270M	66.8M	32.2M	$140.38	633
2025 Q2	98.8M	$12.4B	+$494M	26.8M	36.3M	$125.69	578
2025 Q1	95.5M	$10.6B	+$7.24M	56M	82.7M	$110.60	579
2024 Q4	94.4M	$12.9B	+$230M	36.2M	38.4M	$136.50	596
2024 Q3	93M	$10.7B	-$150M	66.6M	71.2M	$115.22	570
2024 Q2	93.6M	$12.9B	+$47.5M	31.3M	90.8M	$137.67	589
2024 Q1	93.2M	$12.9B	+$116M	47.4M	69.7M	$137.92	580
2023 Q4	92.3M	$12.2B	+$5.24M	44.3M	55.4M	$131.76	545
2023 Q3	92M	$10.4B	+$38.9M	46.3M	56.7M	$112.50	508
2023 Q2	91.5M	$8.63B	+$37.9M	32.8M	34.5M	$94.30	452
2023 Q1	90.9M	$9.19B	+$67.3M	22.9M	13.5M	$101.22	481
2022 Q4	90.1M	$10.8B	+$104M	3.65M	13.2M	$119.44	525
2022 Q3	90.5M	$9.61B	-$33.1M	4.41M	19.8M	$106.21	451
2022 Q2	89.7M	$8.74B	-$27.5M	14.6M	49.3M	$97.48	426
2022 Q1	90.1M	$8.45B	+$146M	65.6M	84.9M	$93.75	413
2021 Q4	89.2M	$7.59B	-$143M	48.4M	41.5M	$85.17	389
2021 Q3	90.2M	$8.66B	-$94.9M	34.8M	59.6M	$95.91	390
2021 Q2	91.4M	$8.89B	-$379M	51.4M	70.1M	$97.32	398
2021 Q1	95.1M	$9.25B	+$548M	50M	59.3M	$97.25	410
2020 Q4	89.4M	$8.57B	-$29.3M	73.1M	30.3M	$95.85	394
2020 Q3	89.7M	$8.63B	-$165M	86M	37.2M	$96.16	410
2020 Q2	91M	$11.1B	+$58.3M	71.9M	71.3M	$122.00	409
2020 Q1	90.5M	$7.83B	+$134M	47.3M	57.6M	$86.55	359
2019 Q4	89M	$9.56B	-$104M	50.9M	88.8M	$107.49	384
2019 Q3	89.7M	$8.08B	+$132M	54.1M	57.8M	$90.11	326
2019 Q2	89M	$7.51B	+$405M	44.9M	69.9M	$84.43	295
2019 Q1	88.4M	$7.79B	-$73.6M	63.8M	81.3M	$88.10	322
2018 Q4	89.6M	$6.38B	-$95.2M	48.9M	73.5M	$71.41	320
2018 Q3	88.6M	$10.9B	-$351M	81.8M	57.6M	$122.95	340
2018 Q2	91.9M	$9.03B	+$3.56M	65.7M	65.3M	$98.24	273
2018 Q1	92M	$7.63B	-$147M	53.9M	63.8M	$82.93	262
2017 Q4	93.8M	$7.28B	-$129M	35.4M	29.1M	$77.59	260
2017 Q3	96M	$5.88B	+$104M	23M	37.1M	$61.28	221
2017 Q2	94.9M	$4.36B	+$661M	21M	15.1M	$46.00	220
2017 Q1	85.1M	$3.68B	+$239M	11.9M	11.2M	$43.30	214
2016 Q4	84.4M	$3.27B	-$80.5M	22.7M	18.4M	$38.70	223
2016 Q3	85.7M	$4.34B	+$54.6M	6.27M	25.9M	$50.64	238
2016 Q2	84.8M	$3.86B	-$118M	10.9M	68.3M	$45.45	225
2016 Q1	87.6M	$3.46B	+$138M	12.5M	17.1M	$39.55	210
2015 Q4	83.4M	$4.72B	+$51.3M	18.3M	20.5M	$56.57	216
2015 Q3	82.8M	$3.29B	-$23.1M	17.7M	53M	$39.79	203
2015 Q2	83.4M	$3.98B	-$77.9M	13.7M	48.5M	$47.76	193
2015 Q1	85.2M	$3.38B	+$406M	16.3M	22M	$39.71	171
2014 Q4	75.2M	$1.68B	+$53.1M	48.6M	13.2M	$22.34	132
2014 Q3	73.3M	$1.15B	+$43.8M	16.4M	15.3M	$15.67	132
2014 Q2	70.4M	$1.05B	+$8.07M	5.87M	6.4M	$14.84	124
2014 Q1	69.8M	$1.12B	+$195M	6.46M	7.29M	$16.10	120